Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

12 Month Open-Label Extension Study of the Effect of Alendronate on Bone in People With Chronic SCI Previously Treated With Teriparatide

NCT02195895 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02195895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02195895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
12 Month Open-Label Extension Study of the Effect of Alendronate on Bone in People With Chronic SCI Previously Treated With Teriparatide
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2014
Completion date
August 5, 2016
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone loss, osteoporosis, spinal cord injury